Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,062Revenue (TTM) $M924Net Margin (%)-20.5Altman Z-Score6.5
Enterprise Value $M15,273EPS (TTM) $-1.2Operating Margin %-13.6Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-18.3Higher ROA y-yY
Price/Book6.610-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsN
Price/Sales16.25-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-5.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-8.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M162ROIC % (ttm)-6.3Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMRNJoel Greenblatt 2015-06-30 Sold Out $112.05 - $140
($123.93)
$ 92.79-25%Sold Out0
BMRNJoel Greenblatt 2015-03-31 Buy $90.28 - $129.14
($105.95)
$ 92.79-12%New holding4,195
BMRNJoel Greenblatt 2014-12-31 Sold Out $67.27 - $94.19
($83.42)
$ 92.7911%Sold Out0
BMRNJoel Greenblatt 2014-09-30 Buy $55.78 - $73
($65.82)
$ 92.7941%New holding3,885
BMRNMeridian Funds 2013-06-30 Sold Out -0.09%$54.72 - $70.3
($62.32)
$ 92.7949%Sold Out0
BMRNMeridian Funds 2013-03-31 Reduce-0.17%$49.2 - $62.39
($56.51)
$ 92.7964%Reduce -69.03%40,700
BMRNMeridian Funds 2012-12-31 Reduce-0.3%$36.78 - $50.17
($45.59)
$ 92.79104%Reduce -60.99%131,400
BMRNGeorge Soros 2012-06-30 Sold Out -0.15%$32.53 - $38.87
($36.01)
$ 92.79158%Sold Out0
BMRNGeorge Soros 2012-03-31 Add0.11%$33.68 - $38.34
($32.99)
$ 92.79181%Add 300.00%300,000
BMRNGeorge Soros 2011-12-31 Reduce-0.05%$30.07 - $35.38
($32.81)
$ 92.79183%Reduce -57.14%75,000
BMRNGeorge Soros 2011-06-30 Add0.07%$24.93 - $28.455
($26.32)
$ 92.79253%Add 862.36%191,510
BMRNMeridian Funds 2011-03-31 Reduce-0.28%$23.46 - $28.29
($25.46)
$ 92.79264%Reduce -51.54%348,800
BMRNGeorge Soros 2011-03-31 Buy 0.01%$23.46 - $28.29
($25.46)
$ 92.79264%New holding19,900
BMRNGeorge Soros 2010-09-30 Sold Out -0.02%$18.24 - $23.09
($20.93)
$ 92.79343%Sold Out0
BMRNMeridian Funds 2010-03-31 Add0.13%$18.75 - $23.81
($20.92)
$ 92.79344%Add 20.83%795,900
BMRNGeorge Soros 2010-03-31 Add$18.75 - $23.81
($20.92)
$ 92.79344%Add 35.87%30,300
BMRNGeorge Soros 2009-12-31 Buy 0.01%$15.49 - $18.98
($17.17)
$ 92.79440%New holding22,300
BMRNMeridian Funds 2009-09-30 Buy 0.53%$13.86 - $18.33
($15.84)
$ 92.79486%New holding658,700
BMRNBill Gates 2009-06-30 Sold Out -0.02%$11.92 - $15.94
($13.79)
$ 92.79573%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMRN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIENAIME JEAN JACQUESCEO 2016-07-18Sell41,666$92.720.08view
Davis George EricEVP, General Counsel 2016-07-07Sell2,167$903.1view
LAWLIS V BRYANDirector 2016-06-20Sell550$82.7712.11view
BIENAIME JEAN JACQUESCEO 2016-06-16Sell41,666$80.5515.2view
SPIEGELMAN DANIEL KEVP, CFO 2016-06-06Sell1,649$89.144.09view
SPIEGELMAN DANIEL KEVP, CFO 2016-05-31Sell20,841$89.883.24view
FUCHS HENRY JEVP, Chief Medical Officer 2016-05-26Sell15,000$87.815.67view
SPIEGELMAN DANIEL KEVP, CFO 2016-05-23Sell3,769$87.076.57view
BAFFI ROBERTEVP, Technical Operations 2016-05-18Sell5,000$87.056.59view
Davis George EricEVP, General Counsel 2016-05-10Sell14,658$85.119.02view

Press Releases about BMRN :

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
Roche Holdings Definitely Not a Lumbering Giant Jul 11 2016 
Spiros Segalas Buys McDonald's, Microsoft, Alibaba May 05 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 
WEEKLY CFO SELLS HIGHLIGHT: VVUS, DIS, SNPS, TXRH, BMRN Mar 04 2012 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 
BioMarin Pharmaceutical Inc. Reports Operating Results (10-K) Feb 24 2011 

More From Other Websites
New Voices in Medical Advocacy Often Are Patients Jul 26 2016
BioMarin to Provide Updated Data for BMN 270 in Hemophilia A in Late Breaking Oral Presentation at... Jul 21 2016
Analysts Gauge Alexion Pharmaceuticals’ Return Potential Jul 21 2016
What Are Roche’s Truest Growth Opportunities? Jul 19 2016
Can The Uptrend Continue for with BioMarin Pharmaceutical (BMRN)? Jul 19 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 19 2016
BioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and... Jul 18 2016
BioMarin to Host Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday,... Jul 14 2016
Biotech: 'We Would Not Be Surprised to See Volatility Continue' Jul 13 2016
These Four Drugs Were Withdrawn by the CHMP in June Jul 12 2016
The Word on the Street: How Analysts See BioMarin Now Jul 11 2016
Why Did BioMarin’s Share Price Tank after Brexit? Jul 11 2016
Coverage Initiated on Select Biotech Equities Jul 11 2016
New Reports on Recent Market Movers BioMarin Pharmaceutical, SemiLEDs, Fitbit and EZCORP Jul 11 2016
Four high-quality biotech companies trading like risky startups Jul 11 2016
How Much Upside Potential Does Alexion Have? Jul 11 2016
Catabasis' DMD Drug in Phase II Open-Label Extension Study Jul 08 2016
BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 9.1% Jul 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)